Cognetivity Neurosciences (CSE:CGN OTCQB:CGNSF), a medical technology company founded at the University of Cambridge, UK, has developed a five-minute cognitive function test, powered by artificial intelligence. Its Integrated Cognitive Assessment (ICA) is an easy-to-use, sensitive, reliable and hugely scalable test that represents a major advance in monitoring brain health.
Delivered via touchscreen devices and the web, the ICA provides a unique end-to-end solution for measuring cognition. It allows early detection of neurological issues, leading to better outcomes for patients and reduced costs for healthcare systems.